Autoimmunity following Hepatitis B vaccine as part of the spectrum of ‘Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants’ (ASIA): analysis of 93 cases
Abstract
Objectives: In this study we analyzed the clinical and demographic manifestations among patients diagnosed with immune/autoimmune-mediated diseases post-hepatitis B vaccination. We aimed to find common denominators for all patients, regardless of different diagnosed diseases, as well as the correlation to the criteria of Autoimmune (Auto-inflammatory) Syndrome induced by Adjuvants (ASIA).
Patients and methods: We have retrospectively analyzed the medical records of 114 patients, from different centers in the USA, diagnosed with immune-mediated diseases following immunization with hepatitis-B vaccine (HBVv). All patients in this cohort sought legal consultation. Of these, 93/114 patients diagnosed with disease before applying for legal consultation were included in the study. All medical records were evaluated for demographics, medical history, number of vaccine doses, peri-immunization adverse events and clinical manifestations of diseases. In addition, available blood tests, imaging results, treatments and outcomes were recorded. Signs and symptoms of the different immune-mediated diseases were grouped according to the organ or system involved. ASIA criteria were applied to all patients.
Results: The mean age of 93 patients was 26.5 ± 15 years; 69.2% were female and 21% were considered autoimmune susceptible. The mean latency period from the last dose of HBVv and onset of symptoms was 43.2 days. Of note, 47% of patients continued with the immunization program despite experiencing adverse events. Manifestations that were commonly reported included neuro-psychiatric (70%), fatigue (42%) mucocutaneous (30%), musculoskeletal (59%) and gastrointestinal (50%) complaints. Elevated titers of autoantibodies were documented in 80% of sera tested. In this cohort 80/93 patients (86%), comprising 57/59 (96%) adults and 23/34 (68%) children, fulfilled the required criteria for ASIA.
Conclusions: Common clinical characteristics were observed among 93 patients diagnosed with immune-mediated conditions post-HBVv, suggesting a common denominator in these diseases. In addition, risk factors such as history of autoimmune diseases and the appearance of adverse event(s) during immunization may serve to predict the risk of post-immunization diseases. The ASIA criteria were found to be very useful among adults with post-vaccination events. The application of the ASIA criteria to pediatric populations requires further study.
Get full access to this article
View all access and purchase options for this article.
References
1. Case CL, King-Thom C. Montagu and Jenner: The campaign against smallpox. SIM News 1997; 47: 58–60.
2. Balfe P. Edward Jenner and vaccination in context: Lady Mary got there first. Microbiol Today 1999; 26: 172–172.
3. Elgouhari HM, Abu-Rajab Tamimi TI, Carey WD. Hepatitis B virus infection: understanding its epidemiology, course and diagnosis. Cleve Clin J Med 2008; 75: 881–889.
4. Dienstag JL. Hepatitis B virus infection. N Engl J Med 2009; 360: 305–305.
5. Tsai WL, Chung RT. Viral hepatocarcinogenesis. Oncogene 2010; 29: 2309–2324.
6. Chang MH. Hepatitis B virus and cancer prevention. Recent Results Cancer Res 2011; 188: 75–84.
7. Szmuness W, Stevens CE, Harley EJ, et al. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N Engl J Med 1980; 303: 833–841.
8. Stevens CE, Taylor PE, Tong MJ, et al. Yeast-recombinant hepatitis B vaccine: efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission. JAMA 1987; 257: 2612–2616.
9. Poovorawan Y, Sanpavat S, Pongpuniert W, et al. Protective efficacy of a recombinant DNA hepatitis B vaccine in neonates of HBe antigen-positive mothers. JAMA 1989; 26: 3278–3281.
10. Marcellin P. Hepatitis B and hepatitis C in 2009. Liver Int 2009; 29(Suppl 1): 1–8.
11. Chang MH. Cancer prevention by vaccination against hepatitis B. Recent Results Cancer Res 2009; 181: 85–94.
12. CDC. Surveillance for acute viral hepatitis, United States, 2006. Surveillance Summaries; 2008/Vol. 57/No. SS-2. MMWR, www.cdc.gov/mmwr.
13. Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y. Vaccines and autoimmunty. Nat Rev Rheumatol 2009; 5: 648–652.
14. Altman A, Szyper-Kravitz M, Shoenfeld Y. HBV vaccine and dermatomyositis. Rheumatol Int 2008; 28: 609–612.
15. Choffray A, Pinquier L, Bachelez H. Exacerbation of lupus panniculitis following anti hepatitis B vaccination. Dermatology 2007; 215: 152–154.
16. Stübgen JP. Neuromuscular disorders associated with Hepatitis B vaccination. J Neurol Sci 2010; 292: 1–4.
17. Mikaeloff Y, Caridade G, Suissa S, Tardieu M. Hepatitis B vaccine and the risk of CNS inflammatory demyelination in childhood. Neurology 2009; 72: 873–880.
18. Evans D, Cauchemez S, Hayden FG. “Prepandemic” immunization for novel influenza viruses, “swine flu” vaccine, Guillain-Barré syndrome, and the detection of rare severe adverse events. J Infect Dis 2009; 200: 321–328.
19. Lasky T, Terracciano GJ, Magder L, et al. The Guillain-Barre syndrome and the 1992–1993 and 1993–1994 influenza vaccines. N Engl J Med 1998; 339: 1797–1802.
20. Shoenfeld Y, Agmon-Levin N. 'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. J Autoimmun 2011; 36: 4–8.
21. Satoh M, Reeves WH. Induction of lupus-associated autoantibodies in BALB/c mice by intraperitoneal injection of pristane. J Exp Med 1994; 180: 2341–2346.
22. Reeves WH, Lee PY, Weinstein JS, Satoh M, Lu L. Induction of autoimmunity by pristane and other naturally occurring hydrocarbons. Trends Immunol 2009; 30: 455–464.
23. Santoro D, Stella M, Montalto G, Castellin S. Lupus nephritis after Hepatitis B vaccination: an uncommon complication. Clin Nephrol 2007; 67: 61–63.
24. Fairweather DL, Rose NR. Women and autoimmune diseases. Emerging Infectious Diseases. http://findarticles.com/p/articles/mi_m0GVK/is_11_10/ai_n7577426/(2004).
25. Bhat A, Naguwa S, Cheema G, Gershwin ME. The epidemiology of transverse myelitis. Autoimmun Rev 2010; 9: A395–A399.
26. Borchers AT, Naguwa SM, Shoenfeld Y, Gershwin ME. The geoepidemiology of systemic lupus erythematosus. Autoimmun Rev 2010; 9: A277–A287.
27. Borchers AT, Uibo R, Gershwin ME. The geoepidemiology of type 1 diabetes. Autoimmun Rev 2010; 9: A355–A365.
28. Brooks WH, Le Dantec C, Pers JO, Youinou P, Renaudineau Y. Epigenetics and autoimmunity. J Autoimmun 2010; 34: J207–J219.
29. Lambert JF, Nydegger UE. Geoepidemiology of autoimmune hemolytic anemia. Autoimmun Rev 2010; 9: A350–A354.
30. Logan I, Bowlus CL. The geoepidemiology of autoimmune intestinal diseases. Autoimmun Rev 2010; 9: A372–A378.
31. Meyer A, Levy Y. Geoepidemiology of myasthenia gravis. Autoimmun Rev 2010; 9: A383–A386.
32. Milo R, Kahana E. Multiple sclerosis: geoepidemiology, genetics and the environment. Autoimmun Rev 2010; 9: A387–A394.
33. Prieto S, Grau JM. The geoepidemiology of autoimmune muscle disease. Autoimmun Rev 2010; 9: A330–A334.
34. Selmi C. The worldwide gradient of autoimmune conditions. Autoimmun Rev 2010; 9: A247–A250.
35. Shapira Y, Agmon-Levin N, Shoenfeld Y. Defining and analyzing geoepidemiology and human autoimmunity. J Autoimmun 2010; 34: J168–J177.
36. Davidson A, Diamond B. Autoimmune diseases. N Engl J Med 2011; 345: 340–350.
37. Shoenfeld Y, Zandman-Goddard G, Stojanovich L, et al. The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases–2008. Isr Med Assoc J 2008; 10: 8–12.
38. Kivity S, Agmon-Levin N, Blank M, Shoenfeld Y. Infections and autoimmunity. Trends Immunol 2009; 30: 409–414.
39. Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Adjuvants and autoimmunity. Lupus 2009; 18: 1217–1225.
40. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003; 349: 1526–1533.
41. Edwards CJ, Syddall H, Jameson K, et al. The presence of anticardiolipin antibodies in adults may be influenced by infections in infancy. QJM 2008; 101: 41–47.
42. Ray P, Black S, Shinefield H. Risk of rheumatoid arthritis following vaccination with tetanus, influenza and hepatitis B vaccination among persons 15–59 years of age. Vaccine 2011; 29: 6592–6597.
43. Iñiguez C, Mauri JA, Larrodé P, et al. Acute transverse myelitis secondary to hepatitis B vaccination. Rev Neurol 2000; 5; 31: 430–432.
44. Renard JL, Guillamo JS, Ramirez JM, et al. Acute transverse cervical myelitis following hepatitis B vaccination. Evolution of anti-HBs antibodies. Presse Med 1999; 28: 1290–1292.
45. Fonseca LF, Noce TR, Teixeira ML, et al. Early-onset acute transverse myelitis following hepatitis B vaccination and respiratory infection: case report. Arq Neuropsiquiatr 2003; 61: 265–268.
46. Piaggio E, Ben Younes A, Desbois S, et al. Hepatitis B vaccination and central nervous system demyelination: an immunological approach. J Autoimmun 2005; 4: 33–37.
47. Tomljenovic L, Shaw CA. Mechanisms of aluminum adjuvant toxicity in pediatric populations. Lupus 2012; 21: 223--230.
48. Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Macrophagic myofasciitis, a vaccine (alum) autoimmune-related disease. Clin Rev Allergy Immunol 2011; 41: 163–168.
Cite article
Cite article
Cite article
OR
Download to reference manager
If you have citation software installed, you can download article citation data to the citation manager of your choice
Information, rights and permissions
Information
Published In
Article first published online: January 10, 2012
Issue published: February 2012
Keywords
PubMed: 22235045
Authors
Metrics and citations
Metrics
Article usage*
Total views and downloads: 608
*Article usage tracking started in December 2016
Altmetric
See the impact this article is making through the number of times it’s been read, and the Altmetric Score.
Learn more about the Altmetric Scores
Articles citing this one
Receive email alerts when this article is cited
Web of Science: 63 view articles Opens in new tab
Crossref: 86
-
Post-Infectious Arthritis and Reactive Arthritis
-
Hallazgos clínicos, de laboratorio y evolución en pacientes con síndro...
-
Quantitative annotations of T-Cell repertoire specificity
-
Vaccines and Autoimmunity—From Side Effects to ASIA Syndrome
-
Aluminum as a CNS and Immune System Toxin Across the Life Span
-
Autoimmune/autoinflammatory syndrome induced by adjuvants: a focus on ...
-
Antigenic characterization of influenza and SARS-CoV-2 viruses
-
Advanced materials for the delivery of vaccines for infectious disease...
-
The Vaccines Induced Autoimmunity
-
Current view on novel vaccine technologies to combat human infectious ...
-
Dysautonomia Following Tetanus, Diphtheria, and Pertussis Vaccine (Tda...
-
Sağlık Öğrencilerinde Aşı Tereddüdü
-
A Guide to Nucleic Acid Vaccines in the Prevention and Treatment of In...
-
Radiation Exposure Predicts Reported Vaccine Adverse Effects in Vetera...
-
The Growing Threat of Vaccine Resistance: a Global Crisis
-
Causality assessment of adverse events following immunization: the pro...
-
Causality assessment of adverse events following immunization: the pro...
-
The Pathophysiology of Arthritis Due to Viruses and Vaccines
-
Vaccines, Adjuvants, and the Mosaic of Autoimmunity
-
Autoimmune/Inflammatory Syndrome Induced by Adjuvants (Shoenfeld’s Syn...
-
Engineering DNA vaccines against infectious diseases
-
Autoimmune diseases after hepatitis B immunization in adults: Literatu...
-
Central Demyelinating Diseases after Vaccination Against Hepatitis B V...
-
Vaccinations in Rheumatology
-
Aluminum as a CNS and Immune System Toxin Across the Life Span
-
Autoimmune/inflammatory syndrome induced by adjuvants
-
RETRACTED: Subcutaneous injections of aluminum at vaccine adjuvant lev...
-
Evidence Refuting the Existence of Autoimmune/Autoinflammatory Syndrom...
-
The putative role of environmental aluminium in the development of chr...
-
References
-
Letter to the editor – HPV vaccine and aut...
-
Severe manifestations of autoimmune syndrome induced by adjuvants (Sho...
-
Severe somatoform and dysautonomic syndromes after HPV vaccination: ca...
-
Autoimmune reaction after anti-tetanus vaccination—description of four...
-
Hepatitis B carrier state among SLE patients: case–control study
-
Rapidly progressive diffuse systemic sclerosis after local vitamins A,...
-
Autoimmune/Inflammatory Syndrome Induced by Adjuvants and Thyroid Auto...
-
Vaccine-related autoimmune hepatitis: the same disease as idiopathic a...
-
Intravascular large B-cell lymphoma associated with silicone breast im...
-
Postural Orthostatic Tachycardia Syndrome (POTS) – A novel member of t...
-
Vaccine-preventable infections in Systemic Lupus Erythematosus
-
On vaccine's adjuvants and autoimmunity: Current evidence and future p...
-
The safety of human papilloma virus-blockers and the risk of triggerin...
-
Systemic Lupus Erythematosus Induced by Vaccines
-
Vaccines, Infections, and Alopecia Areata
-
Introduction
-
Answers to Common Misconceptions Regarding the Toxicity of Aluminum Ad...
-
Vaccination in Patients with Autoimmune Inflammatory Rheumatic Disease...
-
Hepatitis B Vaccination and Autoimmunity
-
Adverse Reactions to Human Papillomavirus Vaccines
-
Fibromyalgia, Chronic Fatigue, Functional Disorders, and Vaccination: ...
-
The first steps towards the era of personalised vaccinology: predictin...
-
Revisiting adverse reactions to vaccines: A critical appraisal of Auto...
-
Treatment considerations in patients with concomitant viral infection ...
-
The epidemiological profile of ASIA syndrome after HPV vaccination: an...
-
Predicting post-vaccination autoimmunity: Who might be at risk?
-
Vaccination and Autoimmunity
-
Anti-Viral Therapy, Epstein–Barr Virus, Autoimmunity, and Chaos (The B...
-
Post-Infectious Arthritis and Reactive Arthritis
-
A sudden onset of a pseudo-neurological syndrome after HPV-16/18 AS04-...
-
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA): clues an...
-
Chronic fatigue syndrome and fibromyalgia following immunization with ...
-
Discovering the pathogenesis of autoimmune diseases at the 9th Interna...
-
Malattie autoimmuni e vaccinazioni
-
Immunization with hepatitis B vaccine accelerates SLE-like disease in ...
-
Are there negative CNS impacts of aluminum adjuvants used in vaccines ...
-
Sjögren's syndrome: Another facet of the autoimmune/inflammatory syndr...
-
Immunization with vaccines and Sjögren's syndrome
-
The Logic of Surveillance Guidelines: An Analysis of Vaccine Adverse E...
-
Influenza and pneumococcal vaccinations of patients with systemic lupu...
-
Postural Orthostatic Tachycardia With Chronic Fatigue After HPV Vaccin...
-
Autism Spectrum Disorders and Aluminum Vaccine Adjuvants
-
Vaccines
-
Aluminum-Induced Entropy in Biological Systems: Implications for Neuro...
-
Autoimmune/inflammatory syndrome induced by adjuvants – a new diagnost...
-
Effects of adjuvants for human use in systemic lupus erythematosus (SL...
-
Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unv...
-
Administration of aluminium to neonatal mice in vaccine-relevant amoun...
-
Human Papilloma Virus Vaccine and Primary Ovarian Failure: Another Fac...
-
Connective Tissue Disease Following Hepatitis B Vaccination
-
Adverse events following immunization with vaccines containing adjuvan...
-
Aluminum in the central nervous system (CNS): toxicity in humans and a...
-
Infectome: A platform to trace infectious triggers of autoimmunity
-
Autoimmune (auto-inflammatory) syndrome induced by adjuvants – ASIA
-
Immune-mediated myelitis following hepatitis B vaccination
-
The spectrum of ASIA: ‘Autoimmune (Auto-inflammatory) Syndrome induced...
Figures and tables
Figures & Media
Tables
View Options
Get access
Access options
If you have access to journal content via a personal subscription, university, library, employer or society, select from the options below:
loading institutional access options
Alternatively, view purchase options below:
Purchase 24 hour online access to view and download content.
Access journal content via a DeepDyve subscription or find out more about this option.
